The Return of He Jiankui: A New Era of Gene Editing
In 2018, He Jiankui made headlines by announcing the birth of the first genetically modified babies, a moment that marked a significant milestone in genetic engineering. Now, after serving three years in prison for ethical violations, He has resurfaced with ambitions that are even more audacious: he aims to eradicate Alzheimer’s disease through genetic modification.
Embracing Controversy
He Jiankui, often referred to as the “Chinese Frankenstein,” does not seek forgiveness for his past actions. He emerged from prison with plans backed by 50 million yuan (approximately 7 million euros) and a self-proclaimed title as a “pioneer of gene editing.” Unlike his previous reckless persona, He now adopts a messianic approach, asserting that he can further rewrite the code of life.
According to He, investors are still keen on his work, suggesting that he continues to operate in a grey area of Chinese law, which prohibits reproductive genetic editing. His framework is labeled as “philanthropic” research, appealing to private entrepreneurs and desperate patients.
What Became of the First Modified Babies?
He’s initial experiment sought to modify embryos to provide immunity to HIV by editing the CCR5 gene. The outcome, however, was less than promising, resulting in what some experts describe as “genetic mosaics.” This means that not all cells within the children were uniformly edited, raising concerns regarding potential unintended mutations. Despite these risks, He claims these children are healthy, further complicating the ethical landscape surrounding genetic modifications.
Targeting Alzheimer’s
The newest challenge for He Jiankui is Alzheimer’s disease, a personal battle that resonates with him, given that his mother suffers from the condition. His proposed method involves introducing a genetic mutation known as APP-A673T, found in the Icelandic population, which might protect against cognitive decline.
Scientists are wary, including esteemed geneticist Kari Stefansson, who highlights the high-risk nature of this approach. The ramifications extend beyond individual health; any minor error in embryo editing could be passed down through generations, making the stakes incredibly high.
A Global Network of Research
Despite being shunned by international academia, He has ambitious plans to continue his research. His strategy involves establishing a transnational network, described by some experts as “guerilla science.” In addition to his work in China with human cell lines, he aims to conduct research in the United States and South Africa, focusing on embryos available from in vitro fertilization processes.
The funding for this ambitious network remains opaque, as He has been reluctant to disclose the identities of his investors, with some reports indicating alternative financing methods such as cryptocurrencies.
The Ethical Gray Zone
He Jiankui openly criticizes American tech giants for their interest in enhancing human traits, labeling such endeavors as a form of eugenics. Nonetheless, the line between his practices and emerging technologies in Silicon Valley is increasingly blurred, particularly as companies advocate for the selection of embryos based on favorable genetic traits.
The Implications of Genetic Modification
One fundamental issue lost amid the hype surrounding DNA editing is the concept that genetics does not solely define an individual. Variances in DNA account for only a small percentage of human characteristics. Moreover, the technical risks associated with embryo DNA analysis can lead to flawed decisions. The race for genetic modification appears tied to deeper societal fears, particularly the anxiety over aging and mortality.
The Dilemma of Future Generations
As He Jiankui navigates this complex landscape, the most critical voice is often missing: that of the future children who might bear the consequences of these irreversible decisions. Is He a visionary, aiming to eliminate debilitating diseases, or an ambitious scientist crossing ethical boundaries? As he prepares for a new wave of genetically modified births, society must confront uncomfortable questions about human identity and the moral determinations that shape future generations.
For now, the “Chinese Darwin” presses on, fueled by available funding and a determined belief that ethics are obstacles to be circumvented in the pursuit of human advancement.